Received Oct 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | z9s4d | IM / RL |
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | f4a7r | IM / RL |
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3m9ds | IM / LL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2142142 | PO / MO |
Patient was mistakenly given Arexvy (adult dose of RSV vaccine). Clinic staff informed mother of incident and called CDC, agency, and Hospital Infection disease on-call number to get information on next steps. Beyforus was suggested by CDC and Hospital ID to counteract Arexvy. Clinic staff gave Beyforus to patient. Between the time of the Arexvy 1400 to Beyforus around 1500, no adverse reactions were noted.
None
None
Vitamin D drops. Pediarix and flu vaccine also given
NKA
N/a